For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit


Rubella Vaccine Inventor Dr. Stanley Plotkin Delivers the Sixth Annual Drukier Lecture and Children's Health Prize Winners Speak at Combined Drukier Institute Event

Dr. Stanley Plotkin, the inventor of the rubella vaccine now in standard use worldwide, and pediatric physician-scientists Dr. Stephen Patrick and Dr. Sallie Permar, who research health conditions that affect newborns, were the featured speakers at a symposium held online on Oct. 20 by Weill Cornell Medicine’s Gale and Ira Drukier Institute for Children's Health.


COVID-19 in children and young people

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has brought distinct challenges to the care of children and adolescents globally. Unusually for a respiratory viral infection, children and adolescents are at much lower risk from symptomatic coronavirus disease 2019 (COVID-19) than any other age group. The near-global closure of schools in response to the pandemic reflected the reasonable expectation from previous respiratory virus outbreaks that children would be a key component of the transmission chain.

Dr. Sallie Permar Appointed Chair of the Department of Pediatrics at Weill Cornell Medicine and Pediatrician-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian Komansky Children’s Hospital

NEW YORK (September 17) — Dr. Sallie Permar, an eminent physician-scientist who focuses on the treatment and prevention of neonatal viral infections, has been appointed chair of the Department of Pediatrics at Weill Cornell Medicine and pediatrician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian Komansky Children’s Hospital, effective Dec. 1.

Study Identifies Abnormal Gene Activity in Distinct Subsets of Immune Cells in Lupus

Abnormal immune activity in lupus, a chronic disease that can cause rashes, fatigue, joint pain, and kidney failure, seems to occur mostly in small subsets of immune cells in patients, potentially enabling better targeting for future treatments, according to a study from scientists at Weill Cornell Medicine and The Jackson Laboratory for Genomic Medicine.

Weill Cornell Medicine
Gale and Ira Drukier Institute for Children's Health
413 E. 69th Street New York, NY 10021